Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04323787 · ClinicalTrials.gov registry record
Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 100,000
- Enrollment target
NCT04323787: Completed study, sponsored by Mayo Clinic.
NCT04323787 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 100,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04323787 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 100,000 participants
- Enrollment target
Study Summary
Researchers are creating a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.
Primary Outcome
Primary outcome will be to measure ICU and hospital mortality up to 7 days of COVID-19 patients
Interventions
- OTHER observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2020-03-30 |
| Est. Completion | 2025-03-31 |
What the finished NCT04323787 record still lists
NCT04323787 is an observational study that tracks outcomes without assigning an intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which observational is the first listed.
NCT04323787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04323787 about?
NCT04323787 is a clinical study titled "Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry". Researchers are creating a real time COVID-19 registry of current ICU/hospital care patterns to allow evaluations of safety and observational effectiveness of COVID-19 practices and to determine the variations in practice across hospitals.
What is the current status of trial NCT04323787?
This trial is currently completed. The enrollment target is 100,000 participants. The study started on 2020-03-30. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT04323787?
The interventions under investigation include: observational (OTHER).
Who is sponsoring clinical trial NCT04323787?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
- NCT04869111 · 100,000 participants · NA
The BrainHealth Project
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI